Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up

Epilepsy and Behavior

Volumn 8, Issue 4, 2006, Pages 736-741

  Lee, Ho Won ^a   Jung, Doo Kyo ^a   Suh, Chung Kyu ^a   Kwon, Soon Hak ^a   Park, Sung Pa ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Adverse effects; Cognition; Epilepsy; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG WITHDRAWAL; EEG ABNORMALITY; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; LEARNING DISORDER; LONG TERM CARE; LOW DRUG DOSE; MALE; MEMORY DISORDER; MONOTHERAPY; NEUROPSYCHOLOGICAL TEST; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; SEIZURE; TASK PERFORMANCE; WORKING MEMORY;

ADOLESCENT; ADULT; ANTICONVULSANTS; COGNITION; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES;

EID: 33646511090     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2006.03.006     Document Type: Article

References (24)

1. Motamedi G., and Meador K. Epilepsy and cognition. Epilepsy Behav 4 Suppl. 2 (2003) S25-S38
2. Aldenkamp A.P., Krom M.D., and Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 44 Suppl. 4 (2003) S21-S29
3. Ortinski P., and Meador K.J. Cognitive side effects of antiepileptic drugs. Epilepsy Behav 5 Suppl. 1 (2004) S60-S65
4. Gilliam F.G., Veloso F., Bomhof M.A.M., et al. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 60 (2003) 196-201
5. Privitera M.D., Brodie M.J., Mattson R.H., et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 107 (2003) 165-175
6. Bootsma H.P.R., Coolen F., Aldenkamp A.P., et al. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to tertiary epilepsy center. Epilepsy Behav 5 (2004) 380-387
7. Tatum W.O., French J.A., Faught E., et al. Postmarketing experience with topiramate and cognition. Epilepsia 42 (2001) 1134-1140
8. Aldenkamp A.P., Baker G., Mulder O.G., et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 41 (2000) 1167-1178
9. Thompson P.J., Baxendale S.A., Duncan J.S., and Sander J.W.A.S. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 69 (2000) 636-641
10. Meador K.J., Loring D.W., Hulihan J.F., Kamin M., and Karim R. Differential cognitive and behavioral effects of topiramate and valproate. Neurology 60 (2003) 1483-1488
11. Mula M., Trimble M.R., Thompson P., and Sander J.W.A.S. Topiramate and word-finding difficulties in patients with epilepsy. Neurology 60 (2003) 1104-1107
12. Lee S., Sziklas V., Andermann F., et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 44 (2003) 339-347
13. Kockelmann E., Elger C.E., and Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res 54 (2003) 171-178
14. Fritz N., Glogau S., Hoffmann J., et al. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav 6 (2005) 373-381
15. Kockelmann E., Elger C.E., and Helmstaedter C. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication. Epilepsy Behav 5 (2004) 716-721
16. Williams J.M. Memory Assessment Scales professional manual (1991), Psychological Assessment Resources, Odessa, FL
17. Wechsler D. Wechsler Memory Scale-Revised Manual (1987), Psychological Corp., San Antonio, TX
18. Reitan R.M., and Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Second ed. (1993), Neuropsychology Press, Tucson, AZ
19. Goodglass H., Kaplan E., and Barresi B. Boston Diagnostic Aphasia Examination-Third Edition (BDAE-3) (2000), Psychological Corp., San Antonio, TX
20. Aldenkamp A.P. Cognitive and behavioral assessment in clinical trials: when should they be done?. Epilepsy Res 45 (2001) 155-157
21. Thompson P. Cognitive and behavioral assessment in clinical trials: when should they be done?. Epilepsy Res 45 (2001) 159-161
22. Arroyo S., Dodson W.E., Privitera M.D., et al. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol Scand 112 (2005) 214-222
23. Lin K.M., Poland R.E., and Lesser I.M. Ethnicity and psychopharmacology. Cult Med Psychiatry 10 (1986) 151-165
24. Silberstein S.D., Ben-Menachem E., Shank R.P., and Wiegand F. Topiramate monotherapy in epilepsy and migraine prevention. Clin Ther 27 (2005) 154-165